Loading...

Urbanization And AI Will Revolutionize Touchless Screening

Published
08 Aug 25
Updated
16 Jun 26
Views
46
16 Jun
US$5.65
AnalystHighTarget's Fair Value
US$10.50
46.2% undervalued intrinsic discount
Loading
1Y
-1.4%
7D
-7.2%

Author's Valuation

US$10.546.2% undervalued intrinsic discount

AnalystHighTarget Fair Value

Last Update 16 Jun 26

EVLV: SAFETY Act Wins And 2026 Manufacturing Ramp Will Drive Upside

Analysts have maintained their consolidated price target for Evolv Technologies Holdings at $10.50, citing recent Q1 results, clarification of misreported data, and commentary on revenue trends, margins, and longer term manufacturing benefits as key supports for this level.

Analyst Commentary on Evolv Technologies Holdings

Recent research coverage on Evolv Technologies Holdings centers on the Q1 report, the clarification of misreported information via an 8-K filing, and updated views on revenue growth, margins, and longer term manufacturing plans. Bullish analysts highlight these elements as key inputs to their view of the stock's valuation and execution risk.

The Q1 results are described as strong, with one firm pointing to 45% year-over-year revenue growth tied to what it calls robust demand and efficient execution. Another firm points to a strong Q1 beat and raised guidance, with revenue and annual recurring revenue growth, margin improvement, and accelerating customer deployments all cited as reasons for greater confidence in Evolv Technologies Holdings.

Clarification of the misreported Q1 data is also seen as important. One research note argues that confusion around third party coverage likely contributed to downside pressure in the stock, particularly among algorithmic traders and retail investors, and that the company’s follow up communication helped reset the narrative around the quarter.

Looking further out, some bullish analysts point to fiscal 2026 as a potential inflection period, referencing expectations for accelerating growth and improved profitability. The ramp of Plexus contract manufacturing is flagged as a factor that could improve value capture and longer term margin structure, with Analyst Day cited as a potential event that could provide more detail on these targets.

Bullish Takeaways

  • Bullish analysts reiterate positive ratings on Evolv Technologies Holdings stock, maintaining or raising price targets in a US$10 to US$10.50 range. They describe this as reflecting confidence in the company’s execution and long term potential.
  • Q1 is described as a strong quarter, with one firm citing 45% year-over-year revenue growth on robust demand and efficient execution. This supports a view that the current valuation is tied closely to delivery against this growth profile.
  • Several research notes point to improving margins, stronger annual recurring revenue trends, and accelerating customer deployments as key supports for higher long term earnings power and potential multiple support.
  • Fiscal 2026 and the ramp of Plexus contract manufacturing are framed as potential catalysts. Bullish analysts view these developments, along with upcoming Analyst Day commentary, as important for reassessing Evolv Technologies Holdings’ growth trajectory and margin outlook.

What’s in the News for Evolv Technologies Holdings

  • Evolv Technologies reported Q1 2026 revenue of US$46.3 million, a 45% year-over-year increase. The company raised full year 2026 revenue guidance to a range of US$175 million to US$180 million and communicated an expectation for positive adjusted EBITDA with high single digit margins, while the stock moved lower following incorrect financial data on some market platforms. (Source: Recent Q1 2026 earnings coverage)
  • The company highlighted expanded deployments of its AI powered Evolv Express and Evolv eXpedite systems across education, healthcare, sports, and entertainment. It added nearly 50 new customers in the quarter and focused on a shift toward purchase subscriptions and an outlook for positive cash flow in the second half of 2026. (Source: Recent Q1 2026 earnings coverage)
  • Evolv eXpedite received SAFETY Act Designation from the U.S. Department of Homeland Security, which means both Evolv eXpedite and Evolv Express are now recognized as Qualified Anti Terrorism Technologies, adding another data point around the regulatory standing of the company’s core products. (Source: DHS SAFETY Act announcement)
  • Evolv Technologies continued to report new and renewed venue agreements, including professional sports teams, large entertainment venues, and education customers. Some contracts involve upgrades to Evolv Express Gen2 hardware and broader deployments of Evolv eXpedite for bag screening. (Source: company client and partnership announcements)
  • A proposed US$15 million cash settlement for a securities class action related to Evolv Technologies was announced, with a court hearing scheduled for September 24, 2026, and key filing and claims deadlines set for Settlement Class members. (Source: securities litigation settlement notice)

Valuation Changes for Evolv Technologies Holdings

  • Fair Value: Maintained at $10.50, indicating no change in the central valuation estimate for Evolv Technologies Holdings stock.
  • Discount Rate: Risen slightly from 8.48% to 8.92%, implying a higher required return being applied to Evolv Technologies Holdings in the updated model.
  • Revenue Growth: Reduced from 22.86% to 19.26%, reflecting a more conservative view of future revenue expansion.
  • Net Profit Margin: Edged higher from 8.08% to 8.32%, indicating a modestly stronger outlook for future profitability on earnings.
  • Future P/E: Lowered from 134.23x to 123.68x, pointing to a slightly less demanding valuation multiple being applied to Evolv Technologies Holdings.
7 viewsusers have viewed this narrative update

Key Takeaways

  • Surging regulatory mandates and expanding venue categories are set to accelerate adoption, greatly enlarging recurring revenue streams and addressable markets ahead of analyst expectations.
  • Operational improvements and new product launches strengthen scalability, boost customer retention, and support margin expansion through increased cross-selling and higher customer value.
  • Heightened regulatory, operational, and competitive pressures, along with ongoing high costs and business model shifts, threaten Evolv's growth, margins, and long-term profitability.

Catalysts

About Evolv Technologies Holdings
    Provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally.
What are the underlying business or industry changes driving this perspective?
  • While analysts broadly agree that Evolv's low market penetration (below 10% in key verticals) presents long-term opportunity, the true addressable market is likely dramatically understated as rising global threats and expanding categories of venues-such as distribution warehouses, transportation sites, and international markets-push adoption well beyond school, hospital, and entertainment settings, fueling a multi-fold acceleration in recurring revenue potential over the next decade.
  • Analyst consensus highlights the impact of regulatory changes like California's mandate for hospital security screening, but this likely underestimates the speed and magnitude of nationwide and potentially international legislation expected in the wake of escalating high-profile incidents, which could drive an exponential increase in mandatory deployments and sustained, higher-margin recurring revenue far sooner than forecast.
  • The combination of accelerating urbanization and the global normalization of AI-based automation will drive widespread, mainstream adoption of touchless weapons detection, removing many historical barriers to large-scale deployment and materially increasing total addressable market size, thus compounding revenue growth well into the future.
  • Evolv's recent leadership overhaul, operational realignment, and robust rebound in customer retention post-FTC inquiry have created a significantly more scalable and resilient organizational platform; this positions the company to unlock higher operating leverage and margin expansion much faster than anticipated as recurring-revenue growth compounds.
  • The launch of new offerings such as the Certified Pre-Owned program and eXpedite not only expands addressable segments-including price-sensitive customers and those needing enhanced screening-but also accelerates cross-selling within the existing base, increasing net customer lifetime value, driving ARR, and supporting higher long-term earnings than generally expected.
Evolv Technologies Holdings Earnings and Revenue Growth

Evolv Technologies Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • This narrative explores a more optimistic perspective on Evolv Technologies Holdings compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
  • The bullish analysts are assuming Evolv Technologies Holdings's revenue will grow by 19.3% annually over the next 3 years.
  • The bullish analysts are not forecasting that Evolv Technologies Holdings will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Evolv Technologies Holdings's profit margin will increase from -22.8% to the average US Electronic industry of 8.3% in 3 years.
  • If Evolv Technologies Holdings's profit margin were to converge on the industry average, you could expect earnings to reach $22.6 million (and earnings per share of $0.11) by about June 2029, up from -$36.5 million today.
  • In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 123.7x on those 2029 earnings, up from -30.2x today. This future PE is greater than the current PE for the US Electronic industry at 33.2x.
  • The bullish analysts expect the number of shares outstanding to grow by 4.64% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.92%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Significant public and legislative scrutiny around surveillance, AI-based security, and data privacy could increase regulatory risk for Evolv's solutions, potentially limiting adoption and shrinking market opportunity-which would in turn constrain revenues and long-term revenue growth.
  • Rapid advances in alternative security technologies, such as biometrics or drone surveillance, and intensifying competition from both incumbents and new entrants may erode Evolv's competitive advantage, creating pricing pressure and threatening revenue growth and margins.
  • Recent operational challenges-including an FTC inquiry, a financial restatement that shifted $3.1 million in revenue, and a full overhaul of the executive team-signal governance and internal control weaknesses, which could undermine investor confidence and weigh on valuation and earnings multiples.
  • Persistent high operating expenses, ongoing restructuring costs, required heavy R&D investment to stay ahead of evolving threats, and the need for substantial capital expenditures to support hardware subscription growth could compress gross margins and limit net margins for an extended period.
  • Earnings visibility may be impeded by the shift to pure subscription models, slower ramp-up in recurring SaaS revenues versus traditional hardware sales, and the challenge of maintaining rapid subscriber growth, all of which increase risk to future revenue, cash flow generation, and long-term profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bullish price target for Evolv Technologies Holdings is $10.5, which represents up to two standard deviations above the consensus price target of $10.12. This valuation is based on what can be assumed as the expectations of Evolv Technologies Holdings's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
  • In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be $271.8 million, earnings will come to $22.6 million, and it would be trading on a PE ratio of 123.7x, assuming you use a discount rate of 8.9%.
  • Given the current share price of $6.13, the analyst price target of $10.5 is 41.6% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Evolv Technologies Holdings?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives